AstraZeneca starts final-stage tests on severe asthma drug
August 14, 2014 at 02:17 AM EDT
LONDON, Aug 14 (Reuters) - AstraZeneca said on Thursday it was starting final-stage Phase III clinical trials for its experimental drug tralokinumab as a treatment for severe asthma.
